Select Issuer Clients

Select Issuer Clients

Issuer Client Profile

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma, a clinical-stage biopharmaceutical company, is transforming the way potent medicines are delivered and administered to provide physicians and patients with more tolerable, safer, effective and powerful therapeutic options in the battle against the growing “superbug” antimicrobial-resistant global public health threat.

View Website

Stock Info

Matinas BioPharma Holdings, Inc. NYSE: MTNB
Day Range
52 wk Range
Market Cap

Stock Quotes are delayed at least 15 minutes.

Issuer Client News Feed

For Investors

Want to take part in the next big idea?

Join Our Network

For Entrepreneurs

Want to explore how we add value?

Submit Your Business Plan